PA
CLVS

Perceptive Advisors’s Clovis Oncology, Inc. CLVS Stock Holding History

Perceptive Advisors’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-150,000
Closed -$4.41M – 134
2018
Q3 		$4.41M Buy
+150,000
New +$5.81M 0.12% 73
2017
Q2 		– Sell
-157,754
Closed -$10M – 168
2017
Q1 		$10M Sell
157,754
-10,000
-6% -$608K 0.57% 42
2016
Q4 		$7.45M Sell
167,754
-3,746
-2% -$132K 0.53% 48
2016
Q3 		$6.18M Buy
+171,500
New +$3.68M 0.4% 59
2015
Q1 		– Sell
-5,138
Closed -$288K – 184
2014
Q4 		$288K Sell
5,138
-25,779
-83% -$1.35M 0.02% 120
2014
Q3 		$1.4M Buy
30,917
+20,000
+183% +$835K 0.14% 80
2014
Q2 		$452K Sell
10,917
-161,300
-94% -$8.31M 0.04% 88
2014
Q1 		$11.9M Buy
172,217
+141,632
+463% +$10.4M 1.25% 25
2013
Q4 		$1.84M Sell
30,585
-164,116
-84% -$8.93M 0.22% 56
2013
Q3 		$11.8M Buy
194,701
+53,874
+38% +$3.82M 0.96% 25
2013
Q2 		$9.43M Buy
+140,827
New +$6.33M 0.95% 24

Other funds holding CLVS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return